Idaho State University at AAPS 2026 PharmSci 360
Oct 25–28, 2026 New Orleans, LA ~4k attendees Website
Idaho State University brings 2 presentations to AAPS 2026 PharmSci 360 in New Orleans. Idaho State University's program centres on breast cancer that has spread to bone. Its work covers lipid nanoparticles decorated with RGD and alendronate to carry angiotensin 1-7 to these tumours, and lab tests of novokinin and a novokinin conjugate.
| Organization | AAPS 2026 PharmSci 360 Attendance |
|---|---|
Idaho State University Pocatello, ID | |
Poster Mon Oct 26 9:30am–10:30am RGD- and Alendronate-Decorated Lipid Nanoparticles for Targeted Delivery of Angiotensin 1-7 to Bone-Metastatic Breast Cancer Poster Mon Oct 26 12:30pm–1:30pm In Vitro Evaluation of Novokinin and Novokinin Conjugate Efficacy in Breast Cancer and Bone Metastasis |
Instantly find 20 buyers from Idaho State University
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction